Home
overview

 

SMi present the 3rd Annual Cancer Vaccines Conference taking place in Central London on Monday 15th and Tuesday 16th September 2014.

This year's event will focus on the pre-clinical entities that are crucial when moving forward in clinical trials.   This will include, assessing antigen discovery and genome sequencing in addition to evaluating biomarkers and chimeric antigen receptors.

There is a growing demand for combination therapies and assessing clinical trial design, especially with failures in the clinic increasing, the question to be asked is how can we learn from this and move forward to ensure phase III developments and regulatory approval

The agenda will focus on in vivo targeting of antigens to dendritic cells for therapeutic anti-cancer vaccines, reviewing preventive vaccine novel adjuvants programmes aswell as evaluating patient stratification.

Furthermore, it will enable a broad range of academics, small biotechs and large pharmaceutical companies to review analytical methods to enable reliability upon standardisation of assays. In addition to assessing the modulation of the tumour microenvironment within early stages of their research and development.

  • An excellent starting point for worldwide benchmarking
  • Hear the latest regulatory insight into market approval and clinical trial design
  • Evaluate case studies from leading academics and industry professionals
  • Assess Strategies to enable positive developments in the field of Cancer Vaccines

 

Professor of Oncology

Professor of Immunochemistry

Professor of Cancer Medicine and Medicinal Oncology

Professor of Experimental Immunology

Director of Immunopharmacology

Medical Assessor, Biologics Licensing

Scientist, Tumour Immunology

Head of Clinical Analysis

Director of Research

Consultant in Medical Oncology

Head of  Immunology

 

Asterand; Bachem Feinchemikalien A G; Baxter Bio Science Baxter Vaccine A G; Beijing Immunotech Applied Sci Ltd; Bellicum Pharmaceuticals; Biopharm Insight; Cancer Research UK; Cancer Vaccines Ltd; Corden Pharma; Duke University Medical Center; Fanelli Haag & Kilger PLLC; Health Production Scotland; Hoffmann-La Roche; Immudex; Immunicum AB; INSERM; Ludwig Institute for Cancer Research; MBL International; Merck; Merck KGaA; Merck Serono; MHRA; National Cancer Institute; Oxford BioMedica (U K) Limited; Roche; Roche Products; Shionogi Limited; Surrey C R C Medical Research Centre; Transgene SA; University of Birmingham; University of Liverpool; University Of Southampton; University Of Tuebingen; University Paris-Diderot; UPMC CNRS; XEME Biopharma Inc;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Joseph  Melenhorst

Joseph Melenhorst , Director of the Product Development & Correlative Sciences laboratory, University Of Pennsylvania

9:10 Therapeutic Vaccines for the treatment of Cancer - Where are we now?

Madiha Derouazi

Madiha Derouazi, CEO , Amal Therapeutics

  • Potential of protein based vaccines
  • Multi-epitopic immune response monitored in the periphery and at the tumor site
  • Persistent effector T cells
  • 9:50 T-VEC – Oncolytic immunotherapy in metastatic melanoma

    Tom Lillie

    Tom Lillie, Therapeutic Area Head, Oncology, Amgen Ltd

    10:30 Morning Coffee

    11:00 Case Study: Oncolytic Vaccines - A step into Cancer Immunotherapy

    John Beadle

    John Beadle, Chief Executive Officer, Psioxus Therapeutics

  • Reviewing the developments of Oncolytic vaccines for the treatment of cancer
  • Assessing vaccine delivery – clinical trial developments 
  • 11:40 T cell immune monitoring: reliability, standardisation and use in clinical trials

    Søren Jakobsen

    Søren Jakobsen, Senior Scientist, Immudex

  • Validity of assays for use in clinical trials
  • Data from proficiency panels
  • Advantages in cancer vaccines and cellular immunotherapies

     

  • 12:20 Networking Lunch

    13:30 Cancer Vaccination in the era of immunomodulatory immunotherapy

    Graham Pawelec

    Graham Pawelec, Professor of Experimental Immunology, University Of Tuebingen

    14:10 Activated allogenec DCs as an off-the-shelf vaccine adjuvant in Cancer Immunotherapy

    Alex Karlsson-Parra

    Alex Karlsson-Parra, CSO, Immunicum AB

  • Immunicum has developed a cellular adjuvant consisting of pre-activated  DCs producing high levels of DC-recruiting and DC-activating factors in a sustained fashion.
  • This concept doesn´t require MHC-compatibility between injected cells and the patient and therefore introduces the possibility of using pre-produced and freeze-stored DCs from healthy blood donors as an ”off-the-shelf” vaccine adjuvant.
  • Data from an ongoing phase I/II clinical trial indicate that intratumoral injection (thus using the patient´s own tumor as antigen source) of pre-activated allogeneic DCs is safe and induce a systemic CTL-mediated anti-tumor response that may prolong survival in patients  with metastatic renal cancer.
  • 14:50 Afternoon Tea

    15:20 Phase I/II trial of a novel antibody DNA immunotherapy, SCIB1 ImmunoBody which targets CD64, in the treatment of Melanoma

    Lindy Durrant

    Lindy Durrant, Joint CEO, Scancell plc.

  • We demonstrate that SCIB1 is safe
  • Of 25 patients, 23 received repeated immunisations of SCIB1 and 20 showed immune responses
  • Detection of objective clinical responses and overall survival times are encouraging
  • 16:00 Assessing the Developments in the field of Cancer Vaccines

    Eric Leire

    Eric Leire, CEO, DanDrit Biotech

    16:40 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Joseph  Melenhorst

    Joseph Melenhorst , Director of the Product Development & Correlative Sciences laboratory, University Of Pennsylvania

    9:10 A Perfect Partnership - A University of Pennsylvania and Novartis Collaboration!

    Joseph  Melenhorst

    Joseph Melenhorst , Director of the Product Development & Correlative Sciences laboratory, University Of Pennsylvania

    9:50 RNActive® for cancer immunotherapy

    Birgit  Scheel

    Birgit Scheel, Director Program Management Oncology, Curevac GmbH

  • Targeting immunotherapy candidates for the treatment of cancer by harnessing the natural power of the immune system to fight disease
  • Current pivotal trials- updates and reviews of the current developments
  • 10:30 Morning Coffee

    11:00 High expectations and harnessing the body's immune system

    John Maudsley

    John Maudsley, CEO, Cancer Vaccines Ltd

  • Basis for and practical limits of immunotherapies
  • Pre-clinical models
  • Clinical progress in cell-based vaccines
  • 11:40 DCVax®-­Direct: A Novel Personalised Immune Therapy for Inoperable and Metastatic Solid Tumours

    Linda F. Powers

    Linda F. Powers, CEO, Chairman of the Board, Northwest Biotherapeutics Inc

    12:20 Networking Lunch

    13:30 What are the key questions in Cancer Immunotherapy

    Christian Ottensmeier

    Christian Ottensmeier, Professor in Experimental Cancer Medicine, University Of Southampton

    14:10 Head and neck cancer immunotherapy: translating laboratory science into a clinical program

    Emma King

    Emma King, CRUK Senior Lecturer in Head and Neck Surgery , Southampton University

    14:50 Biomarker-guided development of novel cancer vaccines- from off-the-shelf to actively personalised

    Harpreet  Singh

    Harpreet Singh, Managing Director, Founder and CSO, Immatics Biotechnologies GmbH

    15:30 Afternoon Tea

    16:00 The Proactive issue of tumor genomic heterogeneity in Immunotherapy

    Michael Hanna

    Michael Hanna, CEO, Vaccinogen

  • The impact in Antigen discovery for Cancer Vaccines
  • Patient population selection for treatment
  • In vivo and in vitro monitoring of the treatment and clinical endpoints
  • Potential for development of epitope based vaccines for treatment and prevention
  • 16:40 Panel Discussion: Assessing Regulatory Approval and Clinical Trial Design

  • What are the implications of manufacturing?
  • What are the regulatory requirements from phase IIb to III?
  • Harpreet  Singh

    Harpreet Singh, Managing Director, Founder and CSO, Immatics Biotechnologies GmbH

    Michael Hanna

    Michael Hanna, CEO, Vaccinogen

    Christian Ottensmeier

    Christian Ottensmeier, Professor in Experimental Cancer Medicine, University Of Southampton

    John Maudsley

    John Maudsley, CEO, Cancer Vaccines Ltd

    17:20 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Alex Karlsson-Parra

    Alex Karlsson-Parra

    CSO, Immunicum AB
    Birgit  Scheel

    Birgit Scheel

    Director Program Management Oncology, Curevac GmbH
    Christian Ottensmeier

    Christian Ottensmeier

    Professor in Experimental Cancer Medicine, University Of Southampton
    Emma King

    Emma King

    CRUK Senior Lecturer in Head and Neck Surgery , Southampton University
    Harpreet  Singh

    Harpreet Singh

    Managing Director, Founder and CSO, Immatics Biotechnologies GmbH
    John Beadle

    John Beadle

    Chief Executive Officer, Psioxus Therapeutics
    Joseph  Melenhorst

    Joseph Melenhorst

    Director of the Product Development & Correlative Sciences laboratory, University Of Pennsylvania
    Linda F. Powers

    Linda F. Powers

    CEO, Chairman of the Board, Northwest Biotherapeutics Inc
    Madiha Derouazi

    Madiha Derouazi

    CEO , Amal Therapeutics
    Tom Lillie

    Tom Lillie

    Therapeutic Area Head, Oncology, Amgen Ltd

    Alex Karlsson-Parra

    CSO, Immunicum AB
    Alex Karlsson-Parra

    Birgit Scheel

    Director Program Management Oncology, Curevac GmbH
    Birgit  Scheel

    Christian Ottensmeier

    Professor in Experimental Cancer Medicine, University Of Southampton
    Christian Ottensmeier

    Emma King

    CRUK Senior Lecturer in Head and Neck Surgery , Southampton University
    Emma King

    Eric Leire

    CEO, DanDrit Biotech
    Eric Leire

    Graham Pawelec

    Professor of Experimental Immunology, University Of Tuebingen
    Graham Pawelec

    Harpreet Singh

    Managing Director, Founder and CSO, Immatics Biotechnologies GmbH
    Harpreet  Singh

    John Beadle

    Chief Executive Officer, Psioxus Therapeutics
    John Beadle

    John Maudsley

    CEO, Cancer Vaccines Ltd
    John Maudsley

    Joseph Melenhorst

    Director of the Product Development & Correlative Sciences laboratory, University Of Pennsylvania
    Joseph  Melenhorst

    Linda F. Powers

    CEO, Chairman of the Board, Northwest Biotherapeutics Inc
    Linda F. Powers

    Lindy Durrant

    Joint CEO, Scancell plc.
    Lindy Durrant

    Madiha Derouazi

    CEO , Amal Therapeutics
    Madiha Derouazi

    Michael Hanna

    CEO, Vaccinogen
    Michael Hanna

    Søren Jakobsen

    Senior Scientist, Immudex
    Søren Jakobsen

    Tom Lillie

    Therapeutic Area Head, Oncology, Amgen Ltd
    Tom Lillie

    Sponsors and Exhibitors

    Supporters

    Workshops

    Tumour Genomic Heterogeneity in Immunotherapy
    Workshop

    Tumour Genomic Heterogeneity in Immunotherapy

    Holiday Inn Regents Park
    17th September 2014
    London, United Kingdom

    Snap Shot of Attendees at Cancer Vaccines 2014

    Download

    Interview with Dr Jos Melenhorst

    Download

    An Interview with Vaccinogen

    Download

    Sponsors and Exhibitors


    Cobra Biologics

    Sponsors and Exhibitors
    http://www.cobrabio.com

    Cobra Biologics is a leading international clinical and commercial manufacturer of biologics and pharmaceuticals with three GMP approved facilities. We offer a broad range of integrated and stand-alone development services, from cell line development to the supply of investigational medicinal products and commercial production. Our manufacturing solutions cover antibodies, recombinant proteins, viruses, phage, DNA, whole cell vaccines, small molecule API, lyophilisation and fill finish. Over 15 years of track record in producing biologics and pharmaceuticals for use in clinical trials has given our people a unique knowledge base as both manufacturer and also as service providers for the global market.


    Immudex

    Sponsors and Exhibitors
    http://www.immudex.com/

    Immudex provides MHC Dextramer reagents for quantification of antigen-specific T cells, and also provides MHC Multimer and Elispot immune monitoring proficiency panel services. The overall goal is to enable simple, accurate and reliable monitoring of antigen-specific cellular immunity, and to promote the routine use of these technologies in vaccine development.


    Northwest Biotherapeutics

    Sponsors and Exhibitors
    http://www.nwbio.com/

    "The Company (NWBio) has received some shareholder inquiries about whether the Company will be presenting at the SMi conference in London on September 27-28, 2017. While anticipating the disclosure of interim blinded data from NWBio’s Phase III trial of DCVax®-L for Glioblastoma, NWBio will not be presenting at this year’s SMi conference.”

    NWBio is developing DCVax® dendritic cell-based therapeutic vaccines. The Company’s DCVax®-L for resectable solid tumors is in a 331-patient Phase III trial for newly diagnosed GBM and Phase II trials in combination with checkpoint inhibitor drugs are planned. The Company’s DCVax®-Direct for inoperable solid tumors has completed a 40-patient Phase I trial for diverse cancers; various Phase II trials are planned.



    Scancell Ltd

    Sponsors and Exhibitors
    http://www.scancell.co.uk

    Scancell is an AIM listed company developing novel treatments for cancer based on its proprietary ImmunoBody® and Moditope® technology platforms which stimulate target specific high avidity T cells. Scancell’s first ImmunoBody®, SCIB1, which is being developed for melanoma, has produced a potent immune response and tumour destruction in late stage patients.

    Media Partners


    Bioportfolio Limited

    Supporters
    http://www.bioportfolio.com

    BioPortfolio.com is a leading news, information and knowledge resource covering the global life science industries impacted by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources


    British Pharmacological Society

    Supporters
    http://www.bps.ac.uk

    The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Antibodies Online

    Supporters
    http://www.antibodies-online.com

    antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.


    Infectious Agents and Cancer

    Supporters
    http://www.infectagentscancer.com/

    Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical and translational research providing an insight into the association between chronic infections and cancer.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Lab Bulletin

    Supporters
    http://www.labbulletin.com

    Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    PharmCast

    Supporters
    http://www.PharmCast.com

    www.PharmCast.com is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals. www.PharmCast.com brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors. It was created and is maintained by pharmaceutical and biotechnology professionals. Visit www.PharmCast.com and discover for yourself why it is so popular among professionals.


    SelectScience

    Supporters
    http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    Biotechnology Europe

    Supporters
    http://www.biotechnology-europe.com

    BIOTECHNOLOGY-EUROPE.com is provided by BIOTECHNOLOGY WORLD, facilitates the exchange of information by promoting research within biotech sector. These include all participants in the sector such as government bodies, researchers, consumers, biotechnology companies, journalists and venture capital companies, biotech nationals organizations. Links and collaborations with other industrial networks add up to the BIOTECHNOLOGY-EUROPE`s own extensive database.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Cancer Biomarkers (CBM)

    Supporters
    http://www.iospress.nl/journal/cancer-biomarkers/

    Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.


    Genetic Engineering News

    Supporters
    http://www.genengnews.com

    Genetic Engineering & Biotechnology News (GEN) is the most authoritative and widely read biotechnology news publication in the world.Published 21 times a year,GEN's unique news and technology focus include the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drugs and biomarker discovery, bioprocessing, clinical research, molecular diagnostics and biobusiness. For a free subscription go to: http://www.genengnews.com/subscriptions.aspx


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    Industry ARC

    Supporters
    http://www.industryarc.com/

    IndustryARC was started by a group of young, passionate professionals along with extensively experienced industry veterans across various business segments. Our focus and expertise is mainly in the field of analytics, market research and consulting. Our singular goal is to provide accurate and affordable research to our clients. Our research team has expertise in diverse fields like Healthcare, Chemicals, Manufacturing, Logistics, Electronics and Automotive. However diverse the expertise maybe, everyone in our team shares one common trait - we love data and we love providing solutions to clients using that data even more! Seeing your business flourish based on our solutions and strategy is what we love the most! IndustryARC publishes more than 30 reports on an annual basis in the mentioned five Industries. Our reports are in-depth and high quality reports that can help decision makers frame better strategies for their business requirements. These reports can be further customized as per your needs.


    Cutting Edge

    Supporters
    http://www.cuttingedgeinfo.com

    Cutting Edge Information provides customized research and benchmarking reports to pharmaceutical, biotechnology and other life science companies. We provide off-the-shelf and customized research for key areas including medical affairs, clinical development, market access, regulatory affairs, marketing management, sales and HCP fair market value.


    Labhoo

    Supporters
    http://www.labhoo.com



    New Medicine

    Supporters
    http://www.nmok.net

    New Medicine's Oncology Knowledgebase is a dynamic, daily updated, fully relational, user-friendly, comprehensive resource in global drug development in oncology.


    Scrip Intelligence

    Supporters
    http://www.scripintelligence.com

    SCRIP Intelligence is the leading source of news and strategic analysis for the global pharmaceutical industry. We filter the flood of information on the industry and apply the knowledge of our extensive network of analysts, journalists and key opinion leaders to provide our readers with timely business-critical market and competitor intelligence.


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. We are an online R&D matching tool that connects Scientifics and organizations involved in discovery, development and delivery of new healthcare products with service and products providers worldwide. Life science information technology is undergoing a revolution. Part of that revolution involves new, unexplored business models, open innovation, open data and collaboration. If you have a project or idea that you would like to propose, develop or run, we can help. A New Collaboration Network Model for Discovery Research and Development • Effective Platform: the 95% • 5.000 registered users // > 15.000 Newsletter subscribers • Geographical background: 45,5% Europe / 37,5% North America / 16,5% Asia / 0,5% ROW • Professional background: Outsourcing Manager, Project Manager, CEO, Business Developer, CSO, Account Manager, Sales & Marketing People, Scientists, R&D. For further information, please visit our website www.contract-biotechnology.com


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Thomson Reuters

    Supporters
    http://thomsonreuters.com/products_services/science/

    Thomson Reuters is the leading source of intelligent information for professionals around the world. We provide essential information to keep you in touch with the rapidly-changing pharmaceutical and chemical markets, expert services to help you make informed, early decisions, and intuitive technology to manage and support your discovery and development activities. Our products give you the intelligence, tools and expertise to help you optimize your IP portfolio, monitor industry developments, identify licensing and partnering opportunities, deliver successful regulatory submissions, and support your scientific messaging, marketing, product positioning, and awareness campaigns.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


    Journal for ImmunoTherapy of Cancer

    Supporters
    http://www.immunotherapyofcancer.org/

    Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.


    IOS Press

    Supporters
    http://www.iospress.nl

    IOS Press publishes about 120 new books and 100 international journals each year covering topics ranging from computer science and mathematics to medicine and the natural sciences. All titles in this catalogue are available online as well as in print. Many titles are covered in the most important abstracting databases, such as Thomson Reuters / ISI, MEDLINE and SciVerse Scopus. Headquartered in Amsterdam with satellite offices in the USA, Germany, India and China, IOS Press has established several strategic co-publishing initiatives. Notable acquisitions included Delft University Press in 2005 and Millpress Science Publishers in 2008. IOS Press journals are available through the highly-regarded MetaPress platform.


    LabRoots

    Supporters
    http://www.labroots.com/

    LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Innovations in Pharmaceutical Technology (IPT)

    Supporters
    http://www.iptonline.com/

    Innovations in Pharmaceutical Technology (IPT) magazine offers in-depth comment and analysis written by experts from within the field. IPT covers the latest developments in drug discovery, laboratory technology, formulation, delivery systems, and other insights and innovations in the field. The magazine also presents sector-specific events, company and individual profiles, and reviews. IPT is a platform for those involved in pharmaceuticals and biotechnology to share their ideas with other key industry figures.

    Now you can also read IPT on the go with the new Samedan app. Click here to download the app for your iPhone or iPad: http://bit.ly/IJECug


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    International Society of Vaccines (ISV)

    Supporters
    https://www.isv-online.org


    Holiday Inn Regents Park

    Carburton Street
    London W1W 5EE
    United Kingdom

    Holiday Inn Regents Park

    Choose the well-connected Holiday Inn London-Regent's Park hotel, with a superb central London location and speedy transport links. Holiday Inn London-Regent's Park is in a leafy and cosmopolitan area of central London, a 10-minute walk from bustling Oxford Street. Leave your car in our NCP managed underground car park, and explore London by Tube. Great Portland Street Tube station is 25 metres from the hotel, from where you can reach the City and Canary Wharf in 30 minutes, and London Heathrow Airport in 45 minutes.

    Wireless Internet is available throughout the hotel, and you can invite up to 300 people to events at the Academy Conference Centre, with an IT technician and break-out zones. Holiday Inn London-Regent's Park is a 10-minute walk from Santander's offices and businesses in the BT Tower. Stroll 5 minutes to Regent's Park, where you'll find London Zoo and pretty Primrose Hill. We're a 10-minute walk from Bond Street boutiques and 20 minutes from Buckingham Palace and cruises on the River Thames.

    Ask our Concierge to plan your day out and book West End theatre tickets. Room Service is available 24 hours at Holiday Inn London-Regent's Park, or dine in the vibrant Junction Restaurant. Our Junction Bar has a menu of light bites, and a hot breakfast buffet is served daily.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.